Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam for hippocampal hyperactivity in psychosis
NCT04277936Phase 2Terminated
- Sponsor
- Vanderbilt University Medical Center
- Start
- May 2020
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of levetiracetam in psychosis, schizophrenia, sponsored by Vanderbilt University Medical Center. Started May 2020; status: terminated.
02
Drugs
levetiracetam
03
Conditions
psychosisschizophrenia
Beyond the preview
Go deeper on NCT04277936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04277936.